sulfasalazine has been researched along with Arterial Diseases, Carotid in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JY | 1 |
| Cho, HJ | 1 |
| Sir, JJ | 1 |
| Kim, BK | 1 |
| Hur, J | 1 |
| Youn, SW | 1 |
| Yang, HM | 1 |
| Jun, SI | 1 |
| Park, KW | 1 |
| Hwang, SJ | 1 |
| Kwon, YW | 1 |
| Lee, HY | 1 |
| Kang, HJ | 1 |
| Oh, BH | 1 |
| Park, YB | 1 |
| Kim, HS | 1 |
1 other study available for sulfasalazine and Arterial Diseases, Carotid
| Article | Year |
|---|---|
Sulfasalazine induces haem oxygenase-1 via ROS-dependent Nrf2 signalling, leading to control of neointimal hyperplasia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Carotid Artery Diseases; | 2009 |